RE:Volumetric 3M (Math-Market-Manipulate)DF, I'm going to go with the angelic little guy makes good. I still feel there is a chance here for Philip to redeem himself in a way that will make even those most bitter gleam with joy.
Appreciate the history lesson. Dr. Phil may not be the visionary that Dr. White was, however his past success with Angiotech came from his expertise and interest in finding ways to improve existing products that have huge potential as seen by the success of Angiotech. They improved the function of the stent and increased the MC10x then he moved onto Sernova where he felt there was a bigger opportunity. Yes we are running out of time/moves but I would also draw those parallels to the other competitors in this field. Its the end of a long race not much left in the tank but victory could be very sweet.